CME Group Inc Class A
CME: XNAS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$749.00 | Nrbz | Qltpcbqzqh |
CME Earnings: High Interest-Rate Futures Volume Drives Strong Growth
Wide-moat CME Group reported strong fourth-quarter results as volatile fixed-income markets drove higher volume for the firm’s interest-rate futures. Revenue increased 19% from last year and 7.6% from last quarter to $1.44 billion. Diluted earnings per share increased 23.4% from last year to $2.37. As we incorporate these results, we do not plan to materially alter our $220 fair value estimate. We see the shares as fairly valued.